Cabotegravir long-acting
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Cabotegravir long-acting, covering 2014-02-10 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants [Phase 1]